期刊文献+

超高效液相串联质谱法测定大鼠格列美脲及其代谢物的血药浓度 被引量:1

Determination of glimepiride and its metabolite in rat plasma by ultra performance liquid chromatography-tandem mass spectrometry
原文传递
导出
摘要 目的建立超高效液相串联质谱法快速测定大鼠体内格列美脲及其代谢物羟基格列美脲的浓度。方法用乙腈沉淀蛋白的方法处理血浆,色谱柱为ACQUITY UPLC HSS T3柱(50 mm×2.1 mm,1.8μm);流动相为乙腈-0.1%甲酸水,梯度洗脱;流速为0.4 m L·min-1;用正离子多离子反应监测(MRM)扫描,内标为甲苯磺丁脲。结果血浆中格列美脲和羟基格列美脲的线性范围为10~800μg·L-1和1~80μg·L-1(r=0.999 9和0.999 5),最低定量限为2.00μg·L-1和0.50μg·L-1,回收率均为94.05%~105.33%。两者的日内、日间精密度RSD均<8.20%。结论该方法操作简便、快捷,灵敏度高,适于大鼠体内格列美脲及其代谢物的药动学研究。 AIM To develop an ultra performance liquid chromatography-tandem mass spectrometry method for the determination of glimepiride and its metabolite( hydroxyglimepiride) in rat plasma. METHODS The plasma was precipitated with 200 μL acetonitrile. An ACQUITY UPLC HSS T3 column( 50 mm × 2. 1 mm,1. 8 μm)was used as the stationary phase. The mobile phase consisted of acetonitrile-0. 1% formic acid water with gradient elution,and the flow rate was 0. 4 m L·min-1. The analytes were detected with positive electrospray ionization in multiple reaction monitoring( MRM) mode and tolbutamide was used as internal standard. RESULTS Excellent linear calibration curves of glimepiride and hydroxyglimepiride were obtained in the concentration range of 10-800μg·L-1and 1-80 μg·L-1( r = 0. 999 9 and 0. 999 5). The lower limit of quantification was 2. 0 μg·L-1and0. 50 μg·L-1. The average recovery was 94. 05%-105. 33%. The intra-and inter-day relative standard deviations were all less than 8. 20%. CONCLUSION The method is simple,rapid and sensitive,which is suitable for pharmacokinetic study of glimepiride and its metabolite in rats.
出处 《中国临床药学杂志》 CAS 2015年第3期162-166,共5页 Chinese Journal of Clinical Pharmacy
基金 浙江省中西医结合学会临床药学科研基金(康恩贝麝香专项)(编号2013LYX014)
关键词 格列美脲 血药浓度 药动学 超高效液相串联质谱法 glimepiride plasma concentration pharmacokinetics ultra performance liquid chroma-tography-tandem mass spectrometry
  • 相关文献

参考文献8

  • 1Xiao-Jia Ni,Zhan-Zhang Wang,De-Wei Shang,Ming Zhang,Jin-Qing Hu,Chang Qiu,Yu-Guan Wen.Simultaneous determination of glimepiride and pioglitazone in human plasma by liquid chromatography–tandem mass spectrometry and its application to pharmacokinetic study[J]. Journal of Chromatography B . 2014 被引量:1
  • 2M.L. Kundlik,B.H. Zaware,S.R. Kuchekar.Rapid and Specific Approach for Direct Measurement of Glimepiride in Human Plasma by LC–ESI-MS–MS Employing Automated 96 Well Format: Application to a Bioequivalence Study[J]. Journal of Chromatographic Science . 2012 (1) 被引量:1
  • 3Kyeumhan Noh,Eunyoung Kim,Taecheon Jeong,MinKyun Na,Moon-Chang Baek,Kwang-Hyeon Liu,Pil-Hoon Park,Beom Soo Shin,Wonku Kang.Simultaneous determination of glimepiride and its metabolites in human plasma by liquid chromatography coupled to a tandem mass spectrometry[J]. Archives of Pharmacal Research . 2011 (12) 被引量:1
  • 4Prashant Musmade,Kranti Talole,Praful Deshpande,Arumugam Karthik,Shriram Pathak,Sureshwar Pandey,Nayanabhirama Udupa.Novel liquid chromatographic method for simultaneous estimation of pioglitazone and glimepiride in rat plasma by solid phase extraction: application to preclinical pharmacokinetic studies[J]. Arzneimittelforschung . 2011 (01) 被引量:1
  • 5Dipti B Ruikar,Sadhana J Rajput.Optimization of the in vitro oxidative biotransformation of glimepiride as a model substrate for cytochrome p450 using factorial design. DARU Journal of Pharmaceutical Sciences . 2012 被引量:1
  • 6El-Enany Nahed M,Abdelal Amina A,Belal Fathalla F,Itoh Yoshinori I,Nakamura Mitsuhiro N.Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma. Chemistry Central journal . 2012 被引量:1
  • 7S.-F. Zhou,Z.-W. Zhou,L.-P. Yang,J.-P. Cai.Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development. Current Medicinal Chemistry . 2009 被引量:1
  • 8Bonfilio R,Peres C,Salgado HR,et al.Multivariate development and validation of a stability-indicating HPLC method for the determination of glimepiride in tablets. Journal of AOAC International . 2013 被引量:1

同被引文献17

  • 1涂厉标,祝永明.HPLC法同时测定人血清中苯巴比妥、苯妥英和卡马西平的浓度[J].中国药师,2005,8(11):934-936. 被引量:7
  • 2Panomvana D, Traiyawong T, Towanabut S. Effect of CYP3A5 geno- types on the pharmacokinetics of carbamazepine when used as mono-therapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients[J]. J Pharm Pharm Sci, 2013,16(4) :502-510. 被引量:1
  • 3Battino D, Croci D, Rossini A, et al. Serum carbamazepine concentra- tions in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data [ J ]. Epilepsia, 2003, 44 (7) :923-929. 被引量:1
  • 4Roveri FL, Paranhos BA, Yonamine M. Determination of phenobarbi- tal in hair matrix by liquid phase microextraction (LPME) and gas chromatography-mass spectrometry (GC-MS) [ J ]. Forensic Sci htt, 2015, 265:75-80. 被引量:1
  • 5Currie RA, Peffer RC, Goetz AK, et al. Phenobarbital and propicon- azole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activa- tion plays in their mode of action[J]. Toxicology,2014, 321:80-88. 被引量:1
  • 6Teo HL, Wong L, Liu Q, et al. Simple and accurate measurement of carbamazepine in surface water by use of porous membrane-protected micro-solid-phase extraction coupled with isotope dilution mass spec- trometry[ J ]. Anal Chim Acta ,2016,912:49-57. 被引量:1
  • 7E1Hamd MA, Wada M, Ikeda R, et al. Validation of an LC-MS/MS Method for the Determination of Propofol, Midazolam, and Carbamas- epine in Rat Plasma: Application to Monitor Their Concentrations Fol- lowing Co-administration[ J ]. Biol Pharm Bull, 2015, 38 ( 8 ) : 1250- 1253. 被引量:1
  • 8de Almeida CA, Oliveira MS, Mallmann CA, et al. Determination of the psychoactive drugs carbamazepine and diazepam in hospital effluent and identification of their metabolites[ J]. Environ Sei Pollut Res lnt, 2015, 22(21 ) :17192-17201. 被引量:1
  • 9陈冰,蔡卫民.抗癫痫药物的治疗药物监测与个体化用药进展(上)[J].中国药师,2010,13(2):197-199. 被引量:12
  • 10陈冰,蔡卫民.抗癫痫药物的治疗药物监测与个体化用药进展(下)[J].中国药师,2010,13(2):200-202. 被引量:4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部